CCR5 and Insulin resistance: Dual CCR2/CCR5 antagonism ameliorates insulin resistance and inflammation in high-fat diet-fed mice and decreases CCL2/CCL4-induced migration of macrophages (190), however there were multiple off-target effects and so this may not be the best option for human therapy (191).